Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Adenocarcinoma

Explore clinical trials studying Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.

201 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Adenocarcinoma trial results

Completed

A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)

NCT03193190

Conditions
Pancreatic Adenocarcinoma
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Helen Diller Fam Comp Can Ctr San Francisco, California, United States
  • Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States
  • Lombardi Cancer Center, Georgetown University Washington D.C., District of Columbia, United States
View all 23 locations
View Trial Details
Completed

Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer

NCT04257448

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • Uniklinik Köln Cologne, Germany
  • Universitätsklinikum Essen Essen, Germany
  • Universitätsklinikum Frankfurt Frankfurt, Germany
  • Universitätsmedizin Göttingen Göttingen, Germany
View Trial Details
Completed

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

NCT02611024

Conditions
Adenoma, Adnexal Diseases, Advanced Solid Tumors, +53 more
Locations
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Massachusetts General Hospital - Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 23 locations
View Trial Details
Completed

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

NCT02723331

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • Mayo Clinic Hospital Scottsdale, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • New York University New York, United States
View Trial Details
Completed

Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma

NCT01144455

Conditions
Pancreatic Adenocarcinoma
Locations
  • Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
View all 59 locations
View Trial Details
Completed

Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer

NCT05673811

Conditions
Metastatic, Neoplasm Metastasis, Neoplasms, +4 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of California - Davis Cancer Center Sacramento, California, United States
  • University of Louisville - Brown Cancer Center Louisville, Kentucky, United States
  • Weill Cornell Medical Center New York, United States
View all 17 locations
View Trial Details

Related conditions